Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Werewolf Therapeutics, Inc. (HOWL) had Debt to Equity Ratio of 2.36 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.53M |
|
-- |
|
-- |
|
$13.27M |
|
$-13.27M |
|
$-0.26M |
|
$-13.53M |
|
$-13.53M |
|
$-13.53M |
|
$-13.53M |
|
$-13.53M |
|
$-13.53M |
|
$-13.27M |
|
$-12.87M |
|
48.60M |
|
49.39M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$48.73M |
|
$4.29M |
|
$9.29M |
|
$58.02M |
|
$38.52M |
|
-- |
|
$7.30M |
|
$45.82M |
|
$12.20M |
|
$12.20M |
|
$12.20M |
|
48.60M |
|
| Cash Flow Statement Financials | |
$-10.60M |
|
-- |
|
-- |
|
$57.95M |
|
$47.35M |
|
$-10.60M |
|
$0.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
2.36 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-110.90% |
|
-110.90% |
|
-23.32% |
|
-110.90% |
|
$0.25 |
|
$-0.21 |
|
$-0.21 |
|